PR Newswire | August 02, 2023
Accrete AI, a leading dual-use AI software company, announced today that it has been awarded a Multiple Award Schedule (MAS) contract by the General Services Administration (GSA), the centralized procurement arm of the federal government. The company will deliver a transformative enterprise solution powered byArgus™, Accrete's dual-use anomaly detection AI Agent.
"We're happy to streamline and expand the procurement options for the defense and intelligence community in order to bring innovation in AI at the speed of light to the U.S. Government.," said Jim Gill, Chief Operating Officer, Accrete AI. "The AI arms race is moving quickly and the government needs to access innovative technologies, especially AI, faster and easier than ever before. The GSA MAS contract will help bring Argus into the right hands at the speed of relevance."
Argus will ultimately reshape the U.S. Government's posture in the open-source information battlespace, facilitating cross-agency communication, eliminating redundant tasks, boosting the analytical efficiency of petabytes of internal and external data including social media, and reducing time to insight from weeks and months to seconds for tens of thousands of analysts.
About Accrete AI
Accrete AI, founded in 2017, delivers configurable, reliable, and accurate dual-use Analytical AI Agents to both government and commercial customers. Analytical AI agents are AI software that learn from domain specific human expertise, perform analytical work that would otherwise require an army of human experts, and generate predictive insight beyond human capacity, enabling enterprise customers to grow in previously unimaginable ways. Accrete is headquartered in Lower Manhattan with offices in Alexandria, Va., and Wellesley, Mass. For more information, visit www.accrete.ai.
Emerging Technology, Government Business
Globenewswire | July 04, 2023
The Government of Canada has announced its intent to lead the fight against cancer at home and around the world with funding announced today that will support the development of a medical isotope ecosystem in Canada. The partnership includes Indigenous communities, Ontario’s nuclear industry, and leading research facilities, academics, and firms working to commercialize novel therapies.
As part of the funding announced today at the Bruce Power Visitors’ Centre, the Saugeen Ojibway Nation (SON) will take the next step in their partnership with Bruce Power to jointly produce, advance and market new isotopes in support of the global fight against cancer, while also working together to create new economic opportunities within the SON territory.
This funding will ultimately enable a pan-Canadian consortium – the Canadian Medical Isotope Ecosystem (CMIE) – to advance and accelerate the development of the next generation of novel medical isotopes and technologies. The CMIE will position Canada as a leader across all stages of the isotope production cycle, most importantly to ensure cancer patients and health care professionals have access to the critical isotopes they need, when they need them.
“Canada is a world leader in medical isotope research and production, and Bruce Power is proud to be among the innovative companies that places Canada at the forefront of nuclear medicine,” said Mike Rencheck, Bruce Power’s President and CEO. “We are honoured to partner with the Saugeen Ojibway Nation to market isotope production and thank the federal government for its support in leveraging this historic opportunity, while creating sustainable economic benefits within the SON territory.”
The Hon. François-Philippe Champagne, Minister of Innovation, Science and Industry, advanced the funding to support projects that strengthen Canada’s leadership position in research, development and production of medical isotopes and pharmaceuticals.
“Our government is proud to partner in the creation of the Canadian Medical Isotope Ecosystem, which includes support for the SON First Nations communities’ partnership with Bruce Power to innovate in the fight against cancer,” said Minister Champagne. “The pandemic has shown us how important it is to have strong domestic production of pharmaceuticals, and we are delivering on our commitment to providing Canadians with the best therapies they need to care for their health. With this investment, we are making our country a major player in the global biomanufacturing and life sciences industry while creating good jobs for Canadians and stimulating the local economy.”
Pam Damoff, Parliamentary Secretary to the Minister of Public Safety and the Member of Parliament for Oakville North-Burlington, has been a strong advocate for Canada’s medical isotope sector, and announced the funding on behalf of Minister Champagne at today’s event.
“With this investment in the creation of the Canadian Medical Isotope Ecosystem, the Government of Canada is taking another major step towards building resiliency in our domestic medical production capabilities, which will help to ensure the health and safety of Canadians in the event of any potential future global supply chain disruptions,” said Damoff. “This investment will not only grow the economy, as the Ecosystem is expected to attract over $75 million in investment, and create or maintain over 600 highly skilled, well-paying jobs, but also contribute to economic reconciliation with the Saugeen Ojibway Nation.”
Bruce Power partnered with the SON in 2019 in an historic collaboration for the marketing of current and new isotopes produced through the first-of-a-kind Isotope Production System (IPS) that was installed at Bruce Power in 2022. The partnership, named Gamzook’aamin aakoziwin, which translates to ‘We are Teaming Up to Fight the Sickness,’ includes a revenue-sharing program that provides a direct benefit to the community.
“Today marks another important milestone in the Gamzook’aamin Aakoziwin partnership between Bruce Power and the Saugeen Ojibway Nation,” said Chief Veronica Smith, Chippewas of Nawash Unceded First Nation. “By working together, patients around the world have access to cancer-fighting treatments made possible through medical isotope production.”
“We are proud to be part of this innovative project, which will deliver benefits beyond the local community, to people across the world in the global fight against cancer,” said Chief Conrad Ritchie, Chippewas of Saugeen First Nation.
The Made-in-Ontario IPS, designed and installed by Isogen (a joint venture between Framatome and Kinectrics) at Bruce Power, irradiates ytterbium-176 to produce lutetium-177, which is then transported to ITM’s manufacturing facility in Germany for processing of pharmaceutical-grade, non-carrier-added lutetium-177 (n.c.a. lutetium-177) and used in various clinical and commercial radiopharmaceutical cancer treatments.
“With commercial production of lutetium-177 well underway at Bruce Power, physicians and their patients worldwide now have access to a new, dependable, large-scale supply of lutetium-177 for their cancer treatments,” said John D’Angelo, Chair, Isogen Corp.
The funding announcement was made possible through Innovation, Science and Economic Development’s Strategic Innovation Fund, which provides major investments in innovative projects that will help grow Canada’s economy for the well-being of all Canadians. The investment will help develop Canadian technologies and support advancements in Canada’s medical isotope industry, supporting projects at Bruce Power, TRIUMF, Centre for Probe Development and Commercialization, McMaster Nuclear Reactor, Canadian Nuclear Laboratories and BWXT Medical.
About Bruce Power
Bruce Power is an electricity company based in Bruce County, Ontario. We are powered by our people. Our 4,200 employees are the foundation of our accomplishments and are proud of the role they play in safely delivering clean, reliable nuclear power to families and businesses across the province and life-saving medical isotopes around the world. Bruce Power has worked hard to build strong roots in Ontario and is committed to protecting the environment and supporting the communities in which we live. Formed in 2001, Bruce Power is a Canadian-owned partnership of TC Energy, OMERS, the Power Workers’ Union and The Society of United Professionals.
PR Newswire | August 07, 2023
Pexip, a company that provides multi-platform software video technology, announced that its Pexip Government Cloud (PGC) Cloud Service Offering (CSO) has received StateRAMP Authorized status in the Moderate security categorization from the StateRAMP Project Management Office (PMO) and the StateRAMP Approvals Committee (SAC). In April, Pexip received an Authority to Operate (ATO) at the Moderate Impact level from the Federal Risk and Authorization Management Program (FedRAMP), sponsored by the U.S. Department of Labor.
The StateRAMP Authorization enables secure and compliant collaboration for state and local agencies on Microsoft Teams. Employees can easily join Microsoft Teams calls using Cloud Video Interop (CVI) from video conferencing systems in meeting rooms or from personal devices, whether from the office or home making collaboration seamless an efficient. Pexip also enables state and local agencies to manage their existing video infrastructure investments, making it a cost-effective solution.
"We are very excited about our StateRAMP authorization and believe it represents another great example of Pexip's commitment to delivering secure and compliant solutions to our government customers," said Peter McCarthy, VP of Public Sector, Pexip.
As agencies move to the cloud, Pexip stands ready to support them at every stage. The StateRAMP-authorized Pexip Government Cloud (PGC) platform offers secure video conferencing as a service, ensuring agencies can engage in productive collaboration while adhering to rigorous security standards. For agencies with the most stringent security requirements, such as On-Premise mandates or GCC-High Teams Tenants, Pexip offers the option to self-host its software. This enables complete data control and interoperability within these specialized environments.
Pexips StateRAMP approval is a testament to its commitment to delivering safe and compliant solutions to its government customers. Pexip's StateRAMP approval includes:
US Department of Defense (DoD) Unified Capabilities Approved Product List (UC APL) authorized
Cryptographic Module Validation Program (CMVP) validated Federal Information Processing Standard (FIPS) 140-2 module #3503
ISO/IEC 27001:2013 certified
Section 508 compliant
General Data Protection Regulation (GDPR) compliant
Supports Health Insurance Portability and Accountability Act (HIPAA) compliance
Supports zero trust security architectures
Pexip enables enterprises and organizations of any size to deploy and use video-based communication and collaboration. The Company’s portfolio of products ranges from self-hosted software to cloud service video solutions. Pexip provides seamless collaboration between previously incompatible video and audio technologies such as professional video conferencing systems, Skype for Business, Microsoft Teams, Google Hangouts Meet, and WebRTC. Pexip’s software-based meeting platform can also be used as a foundation for service provider offerings. Pexip has HQ in Oslo, Norway, main offices in London, UK, New York and Reston, US and Sydney, Australia, as well as sales offices across the globe.